ArticleEuropean journal of neurology2025
Outcomes of cerebrovascular disease in muscular dystrophies: A propensity-matched nationwide analysis.
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Impact of Readmission Hospital Site on Outcomes in Patients With Intracerebral Hemorrhage Undergoing Surgery: A Nationwide Cohort Study.Journal of the American Heart Association · 2026Article
- Thiamine use and short-term prognosis in critical cerebrovascular disease: a propensity score matched retrospective analysis from the MIMIC-IV database.BMC neurology · 2025Observational
- Neglected outcomes of cerebrovascular disorders in neuromuscular diseases.European journal of neurology · 2025Article
- Outcomes of cerebrovascular disease in muscular dystrophies: A propensity-matched nationwide analysis.European journal of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeThe literature lacks large studies on outcomes of cerebrovascular disease (CVD) in patients with muscular dystrophies (MDs). Previous studies primarily focused on ischemic stroke. CVD can add considerable morbidity in patients with MD. We aimed to study the outcomes of CVD in patients with MDs using a national database.
methodsData were abstracted from the 2010-2021 Nationwide Readmission Database. We identified hospitalizations for CVDs including ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and other unspecified CVDs. We used propensity-score matching to account for selection bias and baseline differences between MD and non-MD patients in type of CVD, age, biological sex, time of discharge, and comorbidity burden. Outcomes were inpatient mortality, 30-day and 90-day readmissions, length of stay, costs and discharge disposition.
resultsThere were an estimated 6,129,132 CVD hospitalizations, of which 0.03% (weighted N = 2098) were for patients with MD. Ischemic stroke was the most common type, followed by intracerebral hemorrhage. MD was associated with 41% lower odds of a routine discharge, 9% greater costs, and 30% lower odds of 90-day all-cause readmissions. Inpatient mortality was higher in the MD cohort, but the difference was not statistically significant. There were no significant differences in other outcomes.
conclusionThe findings of this study provide new insights into the outcomes of CVD in MD patients, highlighting the need for enhanced access to post-discharge care in such patients. Improved post-discharge care may help reduce readmissions and avoid longer hospital stays. This study could be valuable for neurologists, rehabilitation physicians, healthcare administrators and economists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.